1
|
Veglia F, Vineis P, Overvad K, et al:
Occupational exposures, environmental tobacco smoke, and lung
cancer. Epidemiology. 18:769–775. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Alberg AJ, Brock MV and Samet JM:
Epidemiology of lung cancer: looking to the future. J Clin Oncol.
23:3175–3185. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Poulain S, Lacomme S, Battaglia-Hsu SF, et
al: Signalling with retinoids in the human lung: validation of new
tools for the expression study of retinoid receptors. BMC Cancer.
9:4232009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Fujiwara K, Fujimoto N, Tabata M, et al:
Identification of epigenetic aberrant promoter methylation in serum
DNA is useful for early detection of lung cancer. Clin Cancer Res.
11:1219–1225. 2005.PubMed/NCBI
|
5
|
Hsu HS, Chen TP, Hung CH, et al:
Characterization of a multiple epigenetic marker panel for lung
cancer detection and risk assessment in plasma. Cancer.
110:2019–2026. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Grote HJ, Schmiemann V, Geddert H, et al:
Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in
bronchial aspirates from patients with suspected lung cancer. Int J
Cancer. 116:720–725. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Herman JG, Graff JR, Myohanen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: a novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
8
|
Belinsky SA, Liechty KC, Gentry FD, et al:
Promoter hypermethylation of multiple genes in sputum precedes lung
cancer incidence in a high-risk cohort. Cancer Res. 66:3338–3344.
2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Ushijima T, Nakajima T and Maekita T: DNA
methylation as a marker for the past and future. J Gastroenterol.
41:401–407. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ikoma H, Ichikawa D, Daito I, et al:
Clinical application of methylation specific-polymerase chain
reaction in serum of patients with gastric cancer.
Hepatogastroenterology. 54:946–950. 2007.PubMed/NCBI
|
11
|
Bu P and Wan YJ: Fenretinide-induced
apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid
receptor beta dependent. BMC Cancer. 7:2362007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Choi CH, Lee KM, Choi JJ, et al:
Hypermethylation and loss of heterozygosity of tumor suppressor
genes on chromosome 3p in cervical cancer. Cancer Lett. 255:26–33.
2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Jin Y, Xu H, Zhang C, et al: Combined
effects of cigarette smoking, gene polymorphisms and methylations
of tumor suppressor genes on non small cell lung cancer: a
hospital-based case-control study in China. BMC Cancer. 10:4222010.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Brabender J, Metzger R, Salonga D, et al:
Comprehensive expression analysis of retinoic acid receptors and
retinoid X receptors in non-small cell lung cancer: implications
for tumor development and prognosis. Carcinogenesis. 26:525–530.
2005. View Article : Google Scholar
|
15
|
Vuillemenot BR, Pulling LC, Palmisano WA,
Hutt JA and Belinsky SA: Carcinogen exposure differentially
modulates RAR-beta promoter hypermethylation, an early and frequent
event in mouse lung carcinogenesis. Carcinogenesis. 25:623–629.
2004. View Article : Google Scholar
|
16
|
Jarmalaite S, Kannio A, Anttila S, Lazutka
JR and Husgafvel-Pursiainen K: Aberrant p16 promoter methylation in
smokers and former smokers with nonsmall cell lung cancer. Int J
Cancer. 106:913–918. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kim DH, Kim JS, Ji YI, et al:
Hypermethylation of RASSF1A promoter is associated with the age at
starting smoking and a poor prognosis in primary non-small cell
lung cancer. Cancer Res. 63:3743–3746. 2003.PubMed/NCBI
|
18
|
Pulling LC, Vuillemenot BR, Hutt JA,
Devereux TR and Belinsky SA: Aberrant promoter hypermethylation of
the death-associated protein kinase gene is early and frequent in
murine lung tumors induced by cigarette smoke and tobacco
carcinogens. Cancer Res. 64:3844–3848. 2004. View Article : Google Scholar
|
19
|
Yanagawa N, Tamura G, Oizumi H, Takahashi
N, Shimazaki Y and Motoyama T: Frequent epigenetic silencing of the
p16 gene in non-small cell lung cancers of tobacco smokers. Jpn J
Cancer Res. 93:1107–1113. 2002. View Article : Google Scholar : PubMed/NCBI
|
20
|
Toulouse A, Morin J, Dion PA, Houle B and
Bradley WE: RARbeta2 specificity in mediating RA inhibition of
growth of lung cancer-derived cells. Lung Cancer. 28:127–137. 2000.
View Article : Google Scholar : PubMed/NCBI
|